Early immunological predictors of neurodevelopmental outcomes in HIV-infected children

Jutarat Mekmullica1, Pim Brouwers, Manhattan Charurat

  • 1Division of Infectious Diseases, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

Insights

Low immune activation in early life, indicated by CD8(+)HLA-DR(+) cells, is linked to better neurodevelopment in children with human immunodeficiency virus (HIV). This finding suggests immune markers can predict developmental outcomes in HIV-infected infants.

Area of Science:

  • Pediatric Immunology
  • Neurodevelopmental Pediatrics
  • Infectious Diseases

Background:

  • Previous studies linked low activated CD8(+) T lymphocytes in early infancy to better immunological prognosis in children with human immunodeficiency virus (HIV).
  • This study aimed to investigate the association between early immune activation and neurodevelopmental outcomes in HIV-infected children.

Purpose of the Study:

  • To determine if early immune activation in HIV-infected children predicts neurodevelopmental prognosis.
  • To examine the relationship between specific immune cell activation markers and cognitive and psychomotor development.

Main Methods:

  • Ninety-eight HIV-infected children with available flow cytometry data (first 2 months) and neurodevelopmental testing (up to 30 months) were analyzed.
  • Children were categorized based on immune activation levels (CD8(+)HLA-DR(+) and CD8(+)CD38(+) cells).
  • Statistical analyses included survival analysis, Cox regression, and longitudinal regression models.

Main Results:

  • A low percentage of CD8(+)HLA-DR(+) cells (
  • This association remained significant after adjusting for CD4 count, viral load, and AIDS progression.
  • A similar, though less significant, association was observed for mental development, while CD8(+)CD38(+) cell levels did not show a significant link to neurodevelopmental outcomes.

Conclusions:

  • Low immune activation, specifically a low percentage of CD8(+)HLA-DR(+) cells, in early infancy is a favorable predictor of psychomotor and mental development in children with HIV.
  • This immune marker's predictive value is independent of other indicators of HIV severity and disease progression.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...